You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 11, 2026

Drug Price Trends for PUREVIT DUALFE PLUS CAPSULE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for PUREVIT DUALFE PLUS CAPSULE

Average Pharmacy Cost for PUREVIT DUALFE PLUS CAPSULE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.39104 EACH 2026-02-18
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.38877 EACH 2026-01-21
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.38689 EACH 2025-12-17
PUREVIT DUALFE PLUS CAPSULE 59088-0112-66 0.38412 EACH 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

PUREVIT DUALFE PLUS CAPSULE Market Analysis and Financial Projection

Last updated: February 13, 2026

Market Analysis and Price Projections for PUREVIT DUALFE PLUS CAPSULE

Market Overview

PUREVIT DUALFE PLUS CAPSULE is a dietary supplement primarily used for bone health, combining vitamin D, calcium, and other micronutrients. The global dietary supplements market, valued at approximately $140.3 billion in 2021, is expected to grow at a compound annual growth rate (CAGR) of 8.2% through 2028 [1]. The segment for bone health supplements accounts for roughly 12% of this market, driven by increasing consumer awareness of osteoporosis and age-related bone issues.

The demand for vitamin D and calcium supplements has increased globally, especially in aging populations in North America, Europe, and Asia-Pacific. Growth factors include:

  • Rising incidence of osteoporosis and osteopenia.
  • Increased healthcare spending on preventive care.
  • Shift toward self-managed health regimes.

In 2022, the market for bone health supplements was valued at approximately $16 billion, projected to reach $27 billion by 2030 [2].

Competitive Landscape

Major players include:

  • Caltrate (AbbVie)
  • Os-Cal (Bayer)
  • Centrum (Pfizer)
  • Nature’s Bounty
  • Now Foods

PUREVIT DUALFE PLUS operates in a competitive environment with branded and private-label options. Niche positioning on enhanced bioavailability and specific nutrient delivery mechanisms influences market share.

Regulatory Environment

Regulatory classification varies by country. In the U.S., dietary supplements are regulated as food under the Dietary Supplement Health and Education Act (DSHEA) of 1994. Claims are restricted to structure/function, not disease treatment. In India, supplements are classified as foods with regulation overseen by the Food Safety and Standards Authority of India (FSSAI). International regulation impacts manufacturing, marketing, and pricing strategies.

Pricing Analysis

Current Price Range

The retail price for PUREVIT DUALFE PLUS capsules varies by region:

Region Price per 30-capsule bottle (USD) Price per capsule (USD)
North America $15 - $20 $0.50 - $0.67
Europe €12 - €18 €0.40 - €0.60
India ₹600 - ₹900 ₹20 - ₹30

Prices differ depending on distribution channels—online e-commerce platforms typically offer discounts of 10-15% compared to brick-and-mortar pharmacies.

Price Drivers

  • Ingredient sourcing costs.
  • Manufacturing scale.
  • Brand positioning and marketing expenses.
  • Regulatory compliance fees.
  • Supply chain logistics.

Price Trends and Forecast

Forecasts anticipate a gradual increase in product prices due to inflation and rising costs of raw ingredients like vitamin D3 and calcium carbonate. An average annual price increase of 3-5% is projected over the next five years.

Market Entry and Growth Opportunities

  • Emerging Markets: Growing awareness of osteoporosis in regions such as Southeast Asia and Latin America presents opportunities.
  • Product Differentiation: Enhanced bioavailability features, organic certifications, or low-sodium formulations can command premium pricing.
  • Private Label Expansion: Contract manufacturing for private labels can expand market penetration at lower price points.

Risks and Barriers

  • Regulatory restrictions on health claims.
  • Competition from generic and private-label brands.
  • Price sensitivity among consumers in price-driven markets.
  • Ingredient sourcing risks impacting margins.

Key Takeaways

  • The global bone health supplement market is expanding, driven by aging demographics and increased awareness.
  • PUREVIT DUALFE PLUS operates within a competitive environment valued at billions, with an average retail price of $15-$20 in North America.
  • Prices are expected to rise modestly, supported by inflation and ingredient costs.
  • Expansion into emerging markets and product differentiation represent growth avenues.

FAQs

1. What factors influence the pricing of PUREVIT DUALFE PLUS capsules?
Ingredient costs, manufacturing scale, marketing, regulatory compliance, and distribution channels shape the product price.

2. How competitive is the bone health supplement market?
It is highly competitive, dominated by large multinationals. Market share depends on brand recognition, formulation, and pricing strategies.

3. What are the growth prospects for the global market?
The market is projected to grow at a CAGR of over 8% through 2028, with Asia-Pacific and Latin America as key emerging markets.

4. Are regulatory differences significant for pricing?
Yes. Regulatory costs and restrictions on claims influence formulation, marketing, and the final retail price.

5. What opportunities exist for premium positioning?
Using bioavailability enhancements, organic certification, or specific formulations targeting niche demographics can justify higher prices.


References

[1] Grand View Research. "Dietary Supplements Market Size, Share & Trends Analysis Report." 2022.
[2] Fortune Business Insights. "Bone Health Supplements Market Size, Share & Industry Analysis." 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.